+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sexual And Reproductive Health Drugs Market Research Reports

Asherman's syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Asherman's syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chlamydia Infections - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chlamydia Infections - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Female Trichomoniasis Vaginalis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Female Trichomoniasis Vaginalis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HPV16-positive Anogenital Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

HPV16-positive Anogenital Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Scabies - Epidemiology Forecast - 2032 - Product Thumbnail Image

Scabies - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Vulvodynia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Vulvodynia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Heavy Menstrual Bleeding (HMB) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Heavy Menstrual Bleeding (HMB) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Hypogonadism - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypogonadism - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Follitropin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Follitropin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Trichomoniasis - Epidemiology Forecast to 2032 (US) - Product Thumbnail Image

Trichomoniasis - Epidemiology Forecast to 2032 (US)

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Human Papillomavirus (HPV) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Human Papillomavirus (HPV) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Sexual and Reproductive Health Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs and treatments related to sexual and reproductive health. These drugs are used to treat conditions such as infertility, erectile dysfunction, and contraception. They also include treatments for sexually transmitted infections, such as HIV and HPV. The market is highly competitive, with many companies offering a range of products and services. Some of the major players in the market include Pfizer, Merck, Bayer, and GSK. These companies are involved in the research and development of new drugs and treatments, as well as the marketing and distribution of existing products. Other companies in the market include Allergan, Teva, and Mylan. Show Less Read more